Insights

Innovative Cell Platforms Clonexpress has developed proprietary technology to generate patient-specific differentiated cell types, including pancreatic beta cells, hepatocytes, and dopaminergic neurons, which are highly relevant for drug discovery, toxicology testing, and personalized medicine applications.

Cancer Research Potential The company's discovery of a unique growth control mechanism in various cancers presents an opportunity to collaborate on developing novel, targeted anti-cancer therapies with minimal side effects, appealing to biotech and pharmaceutical partners seeking innovative treatments.

Custom Cell Line Services Clonexpress offers custom development of tumor and primary cell lines from client samples, making it a valuable partner for research organizations needing specialized cell models for disease research, drug screening, and validation studies.

Research Reagents Portfolio The extensive catalog of human CNS and other primary cells, including neuronal and endothelial cell lines, provides a versatile solution for neuroscience and vascular research institutions looking for high-quality, ready-to-use research materials.

Technology & Validation With advanced assays and close-to-normal cell lines, Clonexpress is well-positioned to serve pharmaceutical companies conducting preclinical testing, offering validated, physiologically relevant cell models that can accelerate drug development pipelines.

Clonexpress, inc. Tech Stack

Clonexpress, inc. uses 4 technology products and services including Amazon Web Services, HTTP/3, Apache Traffic Server, and more. Explore Clonexpress, inc.'s tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • HTTP/3
    Web & Portal Technology
  • Apache Traffic Server
    Web Servers
  • LiteSpeed
    Web Servers

Media & News

Clonexpress, inc.'s Email Address Formats

Clonexpress, inc. uses at least 1 format(s):
Clonexpress, inc. Email FormatsExamplePercentage
LastF@clonexpress.comDoeJ@clonexpress.com
50%
LastF@clonexpress.comDoeJ@clonexpress.com
50%

Frequently Asked Questions

Where is Clonexpress, inc.'s headquarters located?

Minus sign iconPlus sign icon
Clonexpress, inc.'s main headquarters is located at 504 E Diamond Ave, Suite G Gaithersburg, Maryland 20877, US. The company has employees across 2 continents, including North AmericaEurope.

What is Clonexpress, inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Clonexpress, inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Clonexpress, inc.'s official website and social media links?

Minus sign iconPlus sign icon
Clonexpress, inc.'s official website is clonexpress.com and has social profiles on LinkedIn.

What is Clonexpress, inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Clonexpress, inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Clonexpress, inc. have currently?

Minus sign iconPlus sign icon
As of October 2025, Clonexpress, inc. has approximately 2 employees across 2 continents, including North AmericaEurope. Key team members include Regional Vice President: T. V. G.. Explore Clonexpress, inc.'s employee directory with LeadIQ.

What industry does Clonexpress, inc. belong to?

Minus sign iconPlus sign icon
Clonexpress, inc. operates in the Biotechnology Research industry.

What technology does Clonexpress, inc. use?

Minus sign iconPlus sign icon
Clonexpress, inc.'s tech stack includes Amazon Web ServicesHTTP/3Apache Traffic ServerLiteSpeed.

What is Clonexpress, inc.'s email format?

Minus sign iconPlus sign icon
Clonexpress, inc.'s email format typically follows the pattern of LastF@clonexpress.com. Find more Clonexpress, inc. email formats with LeadIQ.

When was Clonexpress, inc. founded?

Minus sign iconPlus sign icon
Clonexpress, inc. was founded in 1992.

Clonexpress, inc.

Biotechnology ResearchUnited States2-10 Employees

Clonexpress has developed a novel technology platform to generate patient-specific differentiated cell types by epigenetic induction.  Clonexpress has developed patient specific pancreatic beta cells, hepatocytes, and dopaminergic neuron cells from adult human fibroblasts and peripheral blood mononuclear cells (three issued patents- US9,029,141B2,US9,394,525 and US10,100,280B2). Clonexpress has developed human pancreatic beta islets cell line (glucose responsive insulin release similar to primary beta cells)  and hepatocyte (metabolism qualified ) cell lines. These cell lines are very close to normal cells and are available for licensing or purchase for drug discovery and toxicology applications.
Clonexpress has recently developed a human microglial cell line available for licensing or purchase.
Custom development of tumor cell lines from tumor samples provided by the  client -successfully developed multiple myeloma and other cell types from tumor samples provided by clients
Custom cell line development of cell lines using primary cells provided by client (both human and non-human) for research use. 
Clonexpres has discovered a common growth control mechanism in different types of cancers, and such growth control mechanism is not present in different normal cells (fibroblasts and mesenchymal cells) capable of continuous growth in culture. This is a totally new paradigm to develop new class of drugs with minimal or no side effects to cure cancer and metastasis. Clonexpress has developed a very sensitive assay to identify the target. Clonexpress is actively seeking funding /partnership opportunities to use this technology to find a cure for different types of cancer. 
Clonexpress also provides human central nervous system (CNS) primary cells - neuronal progenitor cells, dopaminnergic neuron cells, astrocytes, and microglial cells, diffetrent endothelial cells, human fibroblasts, bone marrow stromal cells, liver mesenchymal cells  to for research.

Section iconCompany Overview

Headquarters
504 E Diamond Ave, Suite G Gaithersburg, Maryland 20877, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1992
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    Clonexpress, inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Clonexpress, inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.